TECH - Bio-Techne Corp -  [ ]

Ticker Details
Bio-Techne Corp
Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products.
IPO Date: March 1, 1989
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $8.69B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.47 | 1.16%
Avg Daily Range (30 D): $0.93 | 1.74%
Avg Daily Range (90 D): $0.97 | 1.64%
Institutional Daily Volume
Avg Daily Volume: .31M
Avg Daily Volume (30 D): 1.84M
Avg Daily Volume (90 D): 1.77M
Trade Size
Avg Trade Size (Sh.): 61
Avg Trade Size (Sh.) (30 D): 60
Avg Trade Size (Sh.) (90 D): 56
Institutional Trades
Total Institutional Trades: 8,023
Avg Institutional Trade: $4.82M
Avg Institutional Trade (30 D): $3.74M
Avg Institutional Trade (90 D): $4.76M
Avg Institutional Trade Volume: .28M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $9.01M
Avg Closing Trade (30 D): $17.14M
Avg Closing Trade (90 D): $19.22M
Avg Closing Volume: 400.08K
 
News
Mar 20, 2026 @ 11:00 AM
ELISpot & FluoroSpot Assay Market Report 2026-2031...
Source: Researchandmarkets.Com
Feb 4, 2026 @ 11:30 AM
Bio-Techne Declares Dividend
Source: Prnewswire
Jan 21, 2026 @ 9:42 AM
Middle East Exosomes Market Research Report 2025-2...
Source: Researchandmarkets.Com
Nov 5, 2025 @ 11:30 AM
BIO-TECHNE DECLARES DIVIDEND
Source: Prnewswire
Sep 15, 2025 @ 9:29 PM
Mdxhealth Announces Closing of Exosome Diagnostics...
Source: Globe Newswire
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $.52 $.24 $.25
Diluted EPS $.52 $.24 $.24
Revenue $1.22B $295.88M $286.56M
Gross Profit $792.76M $191.28M $188.11M
Net Income / Loss $81.1M $38.01M $38.19M
Operating Income / Loss $116.97M $54.46M $47.66M
Cost of Revenue $422.82M $104.6M $98.44M
Net Cash Flow $-16.15M $27.5M $-16.01M
PE Ratio 106.83    
Splits
Nov 30, 2022 4:1
Nov 10, 2022 4:1
Dec 04, 2000 2:1